ACCURAY INC

Accuray designs, manufactures, and sells robotic radiation therapy systems for tumor treatment. The company operates two primary product platforms: CyberKnife, a robotic stereotactic radiosurgery system used for extracranial tumors including those of the spine, breast, kidney, liver, lung, pancreas, and prostate; and TomoTherapy, which includes the Radixact System for integrated radiation treatment planning and delivery. The company also offers complementary software systems such as its iDMS data management platform and precision treatment planning system, along with post-sale customer support, installation, training, and professional services.

Revenue derives from direct sales of radiation therapy equipment to hospitals and standalone treatment facilities, supplemented by ongoing service contracts and software licensing. Accuray distributes its products through a combination of direct sales channels and indirect relationships with distributors, sales agents, and group purchasing organizations. In the United States, the company maintains its own sales organization; internationally, it employs both direct sales and distributor networks across markets in Canada, Latin America, Asia, Australia, New Zealand, Europe, the Middle East, India, Africa, Japan, and China.

The company operates with approximately 990 full-time employees and maintains headquarters in Madison, Wisconsin. Accuray was incorporated in Delaware in 1990 and is listed on Nasdaq with a market capitalization of approximately $100 million.